Silk fibroin and sericin have been widely used as a biomaterial for many different purposes. In this study, the properties of crosslinked fibroin/sericin 90/10 films have been investigated using two different crosslinkers poly(ethylene glycol) diglycidyl ether 600 (PEG-DE) and genipin. The films were characterized by molecular weight, fibroin conformation, crystallinity, and thermal stability. Both PEG-DE and genipin cross-linkers stabilized the random/α-helix structures in the fibroin and prevented phase separation between fibroin and sericin that occurs with non-crosslinked materials. The genipin crosslinked film displayed highest elongation at break and tensile strength. The in vitro cytotoxicity of the materials was assessed by lactate dehydrogenase activity and the viability was based on the tetrazolium salt and WST-1 tests. All films exhibited good biocompatibility and supported cell adhesion and proliferation.
Altman GH, Diaz F., Jakuba C., Calabro T., Horan RL, Chen J., et al. Silk-based biomaterials. Biomaterials2003; 24: 401-416.
2.
Kim UJ, Park J., Kim HJ, Wada M. and Kaplan DLThree dimensional aqueous-derived biomaterial scaffolds from silk fibroin . Biomaterials2005; 26: 2775-2785.
3.
Vepari C. and Kaplan DLSilk as a biomaterial. Prog Polym Sci2007 ; 32: 991-1007.
4.
Hofmann S., Hagenmuller H., Koch AM, Muller R., Vunjak-Novakovic G., Kaplan DL, et al. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials2007; 28: 1152-116.
5.
Min BM, Lee G., Kim SH, Nam YS, Lee TS and Park WHElectrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratino- cytes and fibroblasts in vitro. Biomaterials2004; 25: 1289-1297.
6.
Unger RE, Peters K., Wolf M., Motta A., Migliaresi C. and Kirkpatrick CJEndothelialization of a non-woven silk fibroin net for use in tissue engineering: growth and gene regulation of human endothelial cells. Biomaterials2004; 25: 5137-5146.
7.
Fini M., Motta A., Torricelli P., Giavaresi G., Nicoli Aldini N., Tschon M., et al. The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials2005; 26: 3527-3536.
8.
Wang Y., Kim UJ, Biasioli DJ, Kim HJ and Kaplan DL In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials2005 ; 26: 7082-7094.
9.
Wang Y., Blasioli DJ, Kim HJ, Kim HS and Kaplan DLCartilage tissue engineering with silk scaffolds and human articular chondrocytes . Biomaterials2006; 27: 4434-444.
10.
Bondar B., Fuchs S., Motta A., Migliaresi C. and Kirkpatrick CJFunctionality of endothelial cells on silk fibroin nets: comparative study of micro- and nanometric fibre size. Biomaterials2008; 29: 561-572.
11.
Kim HJ, Kim UJ, Kim HS, Li C., Wada M., Leisk GG, et al. Bone tissue engineering with premineralized silk scaffolds. Bone2008; 42: 1226-1234.
12.
Wang X., Kluge JA, Leisk GG and Kaplan DLSonication-induced gelation of silk fibroin for cell encapsulation . Biomaterials2008; 29: 1054-1064.
13.
Motta A., Migliaresi C., Lloyd AW, Denyer SP and Santin M.Serum protein adsorption on silk fibroin fibres and membranes: surface opsonization and binding strength. J Bioact Compat Polym2002; 17: 23-35.
14.
Santin M., Denyer SP, Lloyd AW and Motta A.Domain-driven binding of fibrin(ogen) onto silk fibroin biomaterials . J Bioact Compat Polym2002; 17: 195-208.
15.
Motta A., Maniglio D., Migliaresi C., Kim HJ, Wang X., Hu X., et al. Silk processing and thrombogenic responses. J Biomat Sci-Polym E2009; 20: 1875-1897.
16.
Soong HK and Kenyon KRAdverse reactions to virgin silk sutures in cataract surgery. Ophthalmology1984; 91: 479-483.
17.
Dewair M., Baur X. and Ziegler K.Use of immunoblot technique for detection of human IgE and IgG antibodies to individual silk proteins. J Allergy Clin Immun1985; 76: 537-542.
18.
Zaoming W., Codina R., Fernandez-caldas E. and Lockey RFPartial characterization of the silk allergens in mulberry silk extract . J Invest Allerg Clin1996; 6: 237-241.
19.
Zhang YQApplications of natural silk protein sericin in biomaterials. Biotechnol Adv2002; 20: 91-100.
20.
Tsujimoto K. , Takagi H., Takahashi M., Yamada H. and Nakamori S.Cryoprotective effect of the serine-rich repetitive sequence in silk protein sericin. J Biochem2001; 129: 979-986.
21.
Sasaki M., Yamada H. and Kato N.Consumption of silk protein sericin elevates intestinal absorption of zinc, iron, magnesium and calcium in rats. Nutr Res2000; 20: 1505-1511.
22.
Sarovart S. , Sudatis B., Meesilpa P., Grady BP and Magaraphan R.The use of sericin as an antioxidant and antimicrobial for polluted air treatment . Rev Adv Mater Sci2003; 5: 193-198.
23.
Takahashi M. , Tsujimoto K., Yamada H., Takagi H. and Nakamori S.The silk protein, sericin, protects against cell death caused by acute serum deprivation in insect cell culture. Biotechnol Lett2003 ; 25: 1805-1809.
24.
Takeuchi A. , Ohtsuki C., Miyazaki T., Tanaka H., Yamazaki M. and Tahinara M.Deposition of bone-like apatite on silk fiber in a solution that mimics extracellular fluid. J Biomed Mater Res2003; 65A: 283-289.
25.
Zhaorigetu S., Yanaka N., Sasaki M., Watanabe H. and Kato N.Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-α. Oncol Rep2003; 10: 537-543.
26.
Padamwar MN and Pawar APSilk sericin and its applications: A review . J Sci Ind Res India2004; 63: 323-329.
27.
Aramwit P. and Sangcakul A.The effects of sericin cream on wound healing in rats. Biosci Biotech Bioch2007; 71: 2473-2477.
28.
Dash BC, Mandal BB and Kundu SCSilk gland sericin protein membranes: fabrication and characterization for potential biotechnological applications. J Biotechnol2009; 144: 321-329.
29.
Murase M.Method for solubilizing and molding cocoon silk, artificial organ made of cocoon silk, and medical element made of cocoon silk. Japan Patent06-166850A. 1994 .
30.
Minoura N., Aiba S., Gotoh Y., Tsukada M. and Imai T.Attachment and growth of cultured fibroblast cells on silk protein matrices . J Biomed Mater Res1995; 29: 1215-1221.
31.
Miyairi S. and Sugiura M.Properties of β-glucosidase immobilized in sericin membrane. J Biosci Bioeng1978; 56: 303-308.
32.
Nakamura K. and Koga Y.Sericin-containing polymeric hydrous gel and method for producing the same. Japan patent2001-106794A. 2001.
33.
Wei T., Li M. and Ruijuan X.Preparation and structure of porous silk sericin materials. Macromol Mat Eng2005; 290: 188-194.
34.
Xie RJ, Li M., Lu S., Sheng W. and Xie Y.Preparation of sericin films and its cytocompatibility. Key Eng Mat2007; 342-343: 241-244.
35.
Moonsri P., Watanesk R., Watanesk S., Niamsup H. and Deming RLFibroin membrane preparation and stabilization by poly(ethylene glycol) diGlycidyl ether. J Appl Polym Sci2008; 108: 1402-1406.
36.
Li M., Tao W., Lu S. and Kuga S.Compliant film of regenerated Antheraea pernyi silk fibroin by chemical crosslinking . Int J Biol Macromol2003; 32: 159-163.
37.
Koo H., Lim K., Jung H. and Park E.Antiinflammatory evaluation of gardenia extract, geniposide and genipin . J Ethnopharmacol2006; 103: 496-500.
38.
Meena R., Prasad K. and Siddhanta AKPreparation of genipin-fixed agarose hydrogel. J Appl Polym Sci2007; 104: 290-296.
39.
Liang H., Chang W., Liang H., Lee M. and Sung H.Crosslinking structures of gelatin hydrogels crosslinked with genipin or a water-soluble carbodiimide. J Appl Polym Sci2004; 91: 4017-4026.
40.
Yao C., Liu B., Chang C., Hsu S. and Chen Y.Preparation of networks of gelatin and genipin as degradable biomaterials . Mater Chem Phys2004; 83: 204-208.
41.
Lien S., Li W. and Huang T.Genipin-crosslinked gelatin scaffolds for articular cartilage tissue engineering with a novel crosslinking method. Mater Sci Eng C-Biomim2008; 28: 36-43.
42.
Kim MS, Jun I., Shin YM, Jang W., Kim SI and Shin H.The development of genipin-crosslinked poly(caprolactone) (PCL)/gelatin nanofibers for tissue engineering applications. Macromol Biosci2010; 10: 91-100.
43.
Sundararaghavan HG, Monteiro GA, Lapin NA, Chabal YJ, Miksan JR and Shreiber DIGenipin-induced changes in collagen gels: correlation of mechanical properties to fluorescence . J Biomed Mater Res2008; 87: 308-320.
44.
Muzzarelli RAA.Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohyd Polym2009 ; 77: 1-9.
45.
Peptu CA, Buhus G., Popa M., Perichaud A. and Costin D.Double crosslinked chitosan-gelatin particulate systems for ophthalmic applications . J Bioact Compat Pol2009; 25: 98-116.
46.
Khurma JR and Nand AVTemperature and pH sensitive hydrogels composed of chitosan and poly(ethylene Glycol). Polym Bull2008; 59: 805-812.
47.
Denkbas E. and Ottenbrite RMPerspectives on: Chitosan drug delivery systems based on their geometries . J Bioact Compat Pol2009; 21: 351-368.
48.
Ko C., Huang J., Huang C and Chu I. Type II collagen-chondroitin sulfate-hyaluronan scaffold crosslinked by genipin for cartilage tissue engineering. J Biosci Bioeng2009; 107: 177-182.
49.
Silva SS, Maniglio D., Motta A., Mano JF, Reis RL and Migliaresi C.Genipin-modified silk-fibroin nanometric nets. Macromol Biosci2008; 8: 766-774.
50.
Silva SS, Motta A., Rodrigues MT, Pinheiro M., Gomes ME, Mano JF, et al. Novel genipin-crosslinked chitosan/silk fibroin sponges for cartilage engineering strategies. Biomacromolecules2008; 9: 2764-2774.
